Status:
UNKNOWN
The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves'Ophthalmopathy
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Graves' Ophthalmopathy
Eligibility:
All Genders
20+ years
Brief Summary
The exact mechanism of the pathogenesis of Graves' ophthalmopathy is still unknown. Histopathologically, extraocular muscle inflammation and orbital fat inflammation are two prominent changes. In the ...
Detailed Description
The exact mechanism of the pathogenesis of Graves' ophthalmopathy (GO) is still unknown. Histopathologically, extraocular muscle inflammation due to lymphoid infiltration, edema and interstitial fibro...
Eligibility Criteria
Inclusion
- patients with Graves ophthalmopathy -
Exclusion
- no
- \-
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
End Date :
July 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00174057
Start Date
August 1 2005
End Date
July 1 2006
Last Update
September 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shu Lang Liao
Taipei, Taiwan